Cargando…
Cytochrome P450 3A4*22, PPAR-α, and ARNT polymorphisms and clopidogrel response
Recent candidate gene studies using a human liver bank and in vivo validation in healthy volunteers identified polymorphisms in cytochrome P450 (CYP) 3A4 gene (CYP3A4*22), Ah-receptor nuclear translocator (ARNT), and peroxisome proliferator-activated receptor-α (PPAR-α) genes that are associated wit...
Autores principales: | Kreutz, Rolf P, Owens, Janelle, Jin, Yan, Nystrom, Perry, Desta, Zeruesenay, Kreutz, Yvonne, Breall, Jeffrey A, Li, Lang, Chiang, ChienWei, Kovacs, Richard J, Flockhart, David A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862586/ https://www.ncbi.nlm.nih.gov/pubmed/24353446 http://dx.doi.org/10.2147/CPAA.S53151 |
Ejemplares similares
-
Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response
por: Kreutz, Rolf P, et al.
Publicado: (2012) -
Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention
por: Kreutz, Rolf P, et al.
Publicado: (2016) -
Efavirenz-mediated induction of omeprazole metabolism is CYP2C19 genotype-dependent
por: Michaud, Veronique, et al.
Publicado: (2013) -
Prediction of Ischemic Events after Percutaneous Coronary Intervention: Thrombelastography Profiles and Factor XIIIa Activity
por: Kreutz, Rolf P., et al.
Publicado: (2018) -
CYP2B6 Genotype‐Dependent Inhibition of CYP1A2 and Induction of CYP2A6 by the Antiretroviral Drug Efavirenz in Healthy Volunteers
por: Metzger, Ingrid F., et al.
Publicado: (2019)